See the Complete Picture.
Published loading...Updated

VitalHub has years of outperformance left, Paradigm Capital says

Summary by Cantech Letter
VitalHub’s (VitalHub Stock Quote, Chart, News, Analysts, Financials TSXV:VHI) steady growth, active acquisition strategy, and solid margins have Paradigm Capital’s Daniel Rosenberg sticking to his “Buy” rating and $12.50 target, as the company positions itself for another year of profitable expansion. In a May 11 research note, Rosenberg said VitalHub is showing strong organic growth […] Source
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cantech Letter broke the news in on Tuesday, May 13, 2025.
Sources are mostly out of (0)